US 11690827
Methods for treating ocular Demodex using lotilaner formulations
granted A61KA61K31/42A61K31/422
Quick answer
US patent 11690827 (Methods for treating ocular Demodex using lotilaner formulations) held by Tarsus Pharmaceuticals, Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tarsus Pharmaceuticals, Inc.
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/42, A61K31/422, A61K47/26, A61K9/0048